<DOC>
	<DOCNO>NCT01231269</DOCNO>
	<brief_summary>Whole body diffusion-weighted imaging functional magnetic resonance imaging technique characterize tissue probe change water diffusion secondary difference tissue microstructure . These change water diffusion result difference signal intensity diffusion-weighted-images quantify apparent diffusion coefficient ( ADC ) . In malignant lesion , extravascular extracellular space ( EES ) diminish , due increase number cell . This restrict water diffusion , identify increase signal intensity ( SI ) native DWI image low ADC . Several study indicate value DWI differentiation benign malignant lymph node , detection tumor recurrence ADC-based prediction treatment outcome various solid tumour ( Koh DM et al , Am J Roentgenol 2007 ) . Patients new diagnosis Hodgkin Non-Hodgkin Lymphoma ( diffuse large B-cell lymphoma , follicular lymphoma , mantle cell lymphoma PTLD ) include study . These patient receive WB-DWI scan treatment , twice treatment ( depend type lymphoma ) completion treatment . The MRI scan perform 3 Tesla-MRI system without contrast administration without expose patient radiation . Whole body diffusion-weighted image prospectively interpret two experienced radiologist , blind clinical imaging data . Findings correlate FDG-18F-2-fluoro-2-deoxy-D-glucose fluorodeoxyglucose , biopsy perform clinical routine ( bone marrow always - soft tissue lesion indicate ) image follow-up . The purpose study : - evaluate Whole body diffusion-weighted image stag lymphoma - evaluate Whole body diffusion-weighted image early predictive biomarker treatment outcome - evaluate Whole body diffusion-weighted image differentiate residual tumor post therapy change</brief_summary>
	<brief_title>Whole-body Diffusion-weighted Magnetic Resonance Imaging Staging Treatment Prediction Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<criteria>every patient new diagnosis Hodgkin NonHodgkin Lymphoma ( diffuse large Bcel lymphoma , mantle cell lymphoma , follicular lymphoma PTLD ) patient general contraindication MRI ( pacemaker , claustrophobia , etc . ) patient type lymphoma describe inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>